Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services.
复制标题
门诊药物治疗项目主管的丙型肝炎相关信念及其与提供 HCV 服务的关系。
DOI：
10.1081/ada-200037544
复制
发表时间：
2004
期刊：
影响因子：
--
通讯作者：
DesJarlais,DonC
中科院分区：
文献类型：
--
作者：
Astone,JanettaM;Strauss,ShielaM;Hagan,Holly;DesJarlais,DonC
丙型肝炎病毒（HCV）继续渗透到美国境内的人群中，尤其是吸毒人群中。因此，吸毒者需要获得 HCV 检测和医疗护理，而戒毒治疗计划非常适合提供这些服务。由于这些项目的负责人是可以影响服务提供决策的看门人，因此他们对为药物治疗项目患者提供特定服务的价值的信念非常重要。美国 121 个门诊药物治疗项目的负责人对一项深入的电话调查做出了回应，其中包括有关他们对在药物治疗项目中提供 HCV 服务的信念的问题。我们构建了一个八项目量表来检验这些信念，并调查它们与实际提供的 HCV 服务之间的关系。总体而言，董事们适度支持在药物治疗期间提供 HCV 医疗服务（现场或通过转诊）。我们的研究结果表明，主任的信念与 HCV 抗体检测、随访检测和 HCV 药物的提供之间存在显着正相关关系。
The hepatitis C virus (HCV) continues to penetrate populations within the United States, especially within the drug‐abusing population. Therefore, drug users need access to HCV testing and medical care, and drug treatment programs are well situated to provide these services. Because directors of these programs are gatekeepers who can influence decisions about service provision, their beliefs about the value of providing particular services for drug treatment program patients are of considerable importance. Directors of 121 outpatient drug treatment programs throughout the United States responded to an in‐depth telephone survey that included questions on their beliefs about providing HCV services in drug treatment programs. We constructed an eight‐item scale to examine these beliefs and investigated the relationship between them and the actual HCV services offered. Overall, directors were moderately supportive of the provision of HCV medical services (on‐site or through referral) during drug treatment. Our findings indicate that there is a positive significant relationship between director's beliefs and the provision of HCV antibody testing, follow‐up testing, and the provision of HCV medication.